Ignite Creation Date:
2025-12-25 @ 4:28 AM
Ignite Modification Date:
2025-12-26 @ 3:31 AM
Study NCT ID:
NCT06876220
Status:
COMPLETED
Last Update Posted:
2025-07-24
First Post:
2023-11-26
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
The Role of Anchoring and Distraction in the Effectiveness of Mindfulness on Reducing Emotional Reactivity
Sponsor:
The University of Hong Kong
Organization:
Study Overview
Official Title:
The Role of Anchoring and Distraction in the Effectiveness of Mindfulness on Reducing Emotional Reactivity
Status:
COMPLETED
Status Verified Date:
2025-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The current study aims to investigate the effectiveness of the 8-week Mindfulness-Based Cognitive Therapy for Life (MBCT-L) on the use of anchoring and distraction as emotion care/regulation strategies. It is hypothesized that anchoring and distraction are related but different processes, which could be evidenced by fMRI. The investigators further hypothesized that mindfulness training could lead to functional changes in the brain, which could also be evidenced by fMRI.
Detailed Description:
To test the hypotheses, the participants will be randomly allocated to either the experimental group or the waitlist control group. Both groups will complete behavioral measures and an fMRI experiment before the experimental group's intervention (T0). The experimental group will receive Mindfulness-Based Cognitive Therapy for Life (MBCT-L) between T0 and T1, while the waitlist control will receive no treatment during this period. Both groups will complete the behavioral measures and the fMRI experiment again after the experimental group finishes the MBCT-L course (T1).
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
False
Is an FDA AA801 Violation?: